Operating Lease, Liability of BIO-RAD LABORATORIES, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
BIO-RAD LABORATORIES, INC. quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • BIO-RAD LABORATORIES, INC. Operating Lease, Liability for the quarter ending 30 Sep 2025 was $192,600,000, a 3.2% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $192,600,000 +$5,900,000 +3.2% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $204,100,000 +$11,600,000 +6% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $167,600,000 -$32,200,000 -16% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $173,100,000 -$32,800,000 -16% 31 Dec 2024 10-Q 29 Oct 2025 2025 Q3
Q3 2024 $186,700,000 -$19,600,000 -9.5% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $192,500,000 +$9,200,000 +5% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $199,800,000 +$16,700,000 +9.1% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $205,900,000 +$16,000,000 +8.4% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $206,300,000 +$25,000,000 +14% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $183,300,000 -$10,900,000 -5.6% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $183,100,000 -$23,400,000 -11% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $189,900,000 -$22,400,000 -11% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $181,300,000 -$31,600,000 -15% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $194,200,000 -$5,300,000 -2.7% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $206,500,000 -$1,100,000 -0.53% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $212,300,000 +$700,000 +0.33% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $212,900,000 +$6,400,000 +3.1% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $199,500,000 -$7,500,000 -3.6% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $207,600,000 -$2,300,000 -1.1% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $211,600,000 +$200,000 +0.1% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $206,500,000 -$19,800,000 -8.7% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $207,000,000 -$14,600,000 -6.6% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $209,900,000 -$17,100,000 -7.5% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $211,400,000 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $226,300,000 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $221,600,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $227,000,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.